Sign in
CompletedNo phase

Hepatitis C Treatment in Probation and Parole Office

Key facts

Who runs it
Jens Rosenau
Where
Lexington, United StatesSee the site
Trial code
Status
Completed
People taking part
77 people enrolled
Started
23 Aug 2022
Ended
31 May 2024
Type of study
Interventional
Treatments tested
  • Telehealth in Parole/Probation Office
Record updated
22 April 2025

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Clients who will be supervised in the probation and parole office for at least 5 months
  • History of hepatitis C
  • Able to obtain health insurance
  • Capacity to provide written, informed consent
  • Life expectancy >1 year

Who cannot take part

  • Negative HCV RNA
  • HIV or HBV co-infection
  • Pregnant or breast-feeding
  • Liver cirrhosis with Child-Turcotte-Pugh score 6 or greater at baseline lab work
  • Subjects with impaired capacity to provide informed consent

Where in United States

  • University of KentuckyLexington, United States

About the trial

What the trial wants to find out

This prospective cohort study compares aims to determine the efficacy and effectiveness of telemedicine-supported on-site linkage to care and treatment in a community probation and parole office (P\&P office) setting and compare the results with a historic control with referral to care. Research participants will be followed in the P\&P office when they report to their officer during regularly scheduled appointments. Participants will receive treatment without having to travel to a specialist's office. The telemedicine visit will include a consultation with an experienced HCV provider such as a hepatologist or an advanced practice provider and a specialty pharmacist who will educate about and monitor HCV treatment. The UK specialty pharmacy will be available to participants and the HCV management team through a 24-hour support line. Participants will be treated per HCV guidelines and insurance preference.

The group in the trial

  • Participants with Hepatitis CTreatment being tested

    Participants will be clients at the Lexington Probation and Parole office who are Hepatitic C positive.

    Treatment: Telehealth in Parole/Probation Office

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective Cohort Study to Determine Effectiveness of Telemedicine-based on Site Hepatitis C Management in Probation and Parole Office
Record updated
22 April 2025